The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...